Overstated conclusions of a pooled analysis of bevacizumab in colon cancer.

Authors :: Goffin JR
Talavera JR
Source :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2006 Jan 20; Vol. 24 (3), pp. 528-9; author reply 529-30.
Publication Year :: 2006

Subjects :: Antibodies, Monoclonal administration & dosage
Antibodies, Monoclonal, Humanized
Bevacizumab
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Fluorouracil administration & dosage
Humans
Leucovorin administration & dosage
Meta-Analysis as Topic
Randomized Controlled Trials as Topic
Treatment Outcome
Antibodies, Monoclonal therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Colonic Neoplasms drug therapy
Research Design standards

Language :: English
ISSN :: 1527-7755
Volume :: 24
Issue :: 3
Database :: MEDLINE
Journal :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Type :: Editorial & Opinion
Accession number :: 16421433
Full Text :: https://doi.org/10.1200/JCO.2005.04.3570